Ultra-Processed Foods and Food Additives in CKD
Clinical Journal of the American Society of Nephrology · 2026-02 · 21 (2) · 321-331
DOI: 10.2215/cjn.0000000789 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Clinical Journal of the American Society of Nephrology, online erschienen am 13.06.2025. Verfasst von Carla Maria Avesani und 6 weiteren Autor:innen. Beteiligte Einrichtung: Division of Renal Medicine, Baxter Novum Department of Clinical Science, Intervention and Technology, Karolinska Institutet, Stockholm, Sweden. Hauptthemen laut MEDLINE: Renal Insufficiency, Chronic, Food Additives, Fast Foods. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
The term ultra-processed food (UPF) was developed almost two decades ago to define foods which have undergone sophisticated industrial processing. Many of these foods contain added sugars, unhealthy fats, salt, and food additives designed to enhance palatability, extend shelf life, and drive high sales. Owing to these convenient characteristics, the sales and consumption of UPF have consistently increased, with the tendency to replace minimally processed foods in the diet. This shift has led to a decrease in dietary quality and to an increase in the consumption of sugars, unhealthy fats, salt, and food additives, the latter raising concerns about potential toxicity. Therefore, UPF consumption has been associated with increased risk of developing noncommunicable diseases, including CKD, and may have an effect on kidney health in each CKD stage. Primary caregivers should be aware that UPF increases the risk of developing CKD. Providers of secondary and tertiary care should note that UPF contributes to the development of metabolic derangements such as metabolic acidosis, hyperkalemia, hyperphosphatemia, dyslipidemia, and dysbiosis. This review provides a summary of the main adverse effects of UPFs on general health as well as on kidney health. In addition, it gives practical guidance on how to define and assess UPF intake in research and clinical settings, with proposed strategies on how to address UPF consumption in individuals with CKD stages 3–5, aiming at reducing UPF consumption and increasing intake of minimally processed healthier food.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Renal Medicine, Baxter Novum Department of Clinical Science, Intervention and Technology, Karolinska Institutet, Stockholm, Sweden.
- Department of Applied Nutrition, Nutrition Institute, Rio de Janeiro State University, Rio de Janeiro, Brazil.
- British Columbia Renal Agency, Island Health Authority, Victoria, British Columbia, Canada.
ORCID-Profile: Carla Maria Avesani, Valeria Cecchini, Alice Sabatino, Bengt Lindholm, Peter Stenvinkel, Daniela Canella, Kelly Picard
Zitieren
APA
Avesani, C. M., Cecchini, V., Sabatino, A., Lindholm, B., Stenvinkel, P., Canella, D., & Picard, K. (2026). Ultra-Processed Foods and Food Additives in CKD. Clinical Journal of the American Society of Nephrology, 21(2), 321-331. https://doi.org/10.2215/cjn.0000000789
Vancouver
Avesani CM, Cecchini V, Sabatino A, Lindholm B, Stenvinkel P, Canella D, et al. Ultra-Processed Foods and Food Additives in CKD. Clinical Journal of the American Society of Nephrology. 2026;21(2):321-331. doi:10.2215/cjn.0000000789
BibTeX
@article{Avesani2026,
author = {Avesani, Carla Maria and Cecchini, Valeria and Sabatino, Alice and Lindholm, Bengt and Stenvinkel, Peter and Canella, Daniela and Picard, Kelly},
title = {Ultra-Processed Foods and Food Additives in CKD},
journal = {Clinical Journal of the American Society of Nephrology},
year = {2026},
volume = {21},
number = {2},
pages = {321--331},
doi = {10.2215/cjn.0000000789}
}
EUVIMED